The global atrial fibrillation drugs market size was valued at USD 24.59 billion in 2024 and is projected to reach from USD ...
If you struggle with atrial fibrillation, evolving technologies at United Regional may be able to help your heart stay ...
Discover how abelacimab reduces bleeding risks in AFib patients by effectively lowering free factor XI levels.
Recent research shows the incredible success of radiofrequency ablation in treating AFib, offering renewed hope for patients.
The atrial fibrillation (AF) device market is experiencing rapid growth, fueled by the rising prevalence of atrial fibrillation, increasing awareness of early diagnosis, and advancements in medical ...
DOYLESTOWN, PA — Doylestown Health is broadening its treatment options for atrial fibrillation patients with a revolutionary ...
WAUSAU, Wis. (WSAW) - A free seminar is being held Wednesday evening in Wausau to educate people about AFib. Atrial ...
A new treatment at Unity Point Health is offering promising results for those with irregular heartbeats, otherwise known as ...
As per a survey, only a fraction of smartwatch users share details of their health stats with a doctor, a misstep that could ...
The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five clinical sites. The Company believes the study's findings support the clinical ...